Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,705.00
Bid: 1,650.00
Ask: 1,710.00
Change: 0.00 (0.00%)
Spread: 60.00 (3.636%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-FTSE falters as Brexit hopes lift pound; domestic stocks rejoice

Fri, 11th Oct 2019 09:07

* FTSE 100 down 0.3%, FTSE 250 up 0.8%

* Brexit deal hopes lift sterling, hit exporters

* Housebuilders, UK banks jump

* WPP, Burberry fall after European rivals cut forecast

* Dart Group climbs higher after hiking profit view
(Adds news items, analyst comments, updates share prices)

By Shashwat Awasthi

Oct 11 (Reuters) - Britain's exporter-heavy FTSE 100 lagged
a trade sentiment-induced rally in global stocks on Friday, as
hopes that a Brexit deal may be clinched by the end of the month
lifted the pound and hammered international firms.

The blue-chip index, whose components book nearly
two-thirds of their earnings in the U.S. dollar, shed 0.3%, as
sterling firmed after Ireland sounded optimism on the chances of
Britain leaving the European Union in an orderly fashion.

"Some EU officials may not agree, but it was enough to light
a fire underneath sterling," Spreadex analyst Connor Campbell
wrote.

Exporter stocks such as Diageo, BAT and
Unilever dragged the most, while healthcare firms
AstraZeneca and GlaxoSmithKline also skidded.

However, stocks considered most sensitive to any Brexit
updates such as housebuilders and UK-focussed banks
advanced, and the domestically-focussed mid-cap index jumped
0.8% by 0744 GMT.

Shares of major blue-chip homebuilders Persimmon,
Barratt, Berkeley and Taylor Wimpey
added between 3.7%-5.6%, while RBS and Lloyds
also rose more than 4% each.

The FTSE 100 fell behind the broader European benchmark
, as well as Asian stocks, which rose after U.S.
President Donald Trump stirred hopes of a trade agreement with
China, calling the first day of talks "very good".

"Given the price action of the last 24 hours, one could
argue the foundations of this rally (in global stocks) have more
sand then cement," Oanda analyst Jeffrey Halley said.

"It will only take one negative comment to crack the edifice
and thus, staying on the sidelines and out of danger is still
the more sensible strategy."

The main index was also hurt by a near 4% drop in ad firm
WPP after French rival Publicis cut its sales
view for the second time, and a 3% fall in luxury brand Burberry
after German rival Hugo Boss cut its annual
forecast.

AIM-listed Dart Group surged 12% after the owner of
British airline and tour operator Jet2 raised its annual profit
view and said it had seen stronger demand for some products
since Thomas Cook collapsed.

The FTSE had confirmed a "Death Cross" pattern in the
previous session as its 50-day moving average (DMA) crossed
below the 200 DMA, a technical pattern usually seen as a warning
that more losses are likely in the near term.
(Reporting by Shashwat Awasthi in Bengaluru; Editing by Bernard
Orr)

More News
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more
22 Nov 2023 09:48

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
21 Nov 2023 11:52

GSK to begin phase 3 trials of low-carbon Ventolin inhaler in 2024

(Alliance News) - GSK PLC on Tuesday said it will begin phase 3 trials of a low carbon version of its metered dose inhaler Ventolin using a "next generation" propellant in 2024.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.